Now showing items 1-1 of 1

    • First-line treatment of metastatic melanoma: role of nivolumab. 

      Force, Jeremy M; Salama, April KS (Immunotargets Ther, 2017)
      Historically, the median overall survival of metastatic melanoma patients was less than 1 year and long-term survivors were rare. Recent advances in therapies have dramatically shifted this landscape with increased survival ...